Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study.

MLA

Volpe, Sara, et al. “Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study.” Nutrients, vol. 16, no. 22, Nov. 2024. EBSCOhost, https://doi.org/10.3390/nu16223841.

APA

Volpe, S., Vozza, A., Lisco, G., Fanelli, M., Racaniello, D., Bergamasco, A., Triggiani, D., Pierangeli, G., De Pergola, G., Tortorella, C., Moschetta, A., & Piazzolla, G. (2024). Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study. Nutrients, 16(22). https://doi.org/10.3390/nu16223841

Chicago

Volpe, Sara, Alfredo Vozza, Giuseppe Lisco, Margherita Fanelli, Davide Racaniello, Alessandro Bergamasco, Domenico Triggiani, et al. 2024. “Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study.” Nutrients 16 (22). doi:10.3390/nu16223841.